Aligos Therapeutics Free Cash Flow (Quarterly) Insights

Aligos Therapeutics Inc (ALGS)

0.7887 -0.03 (-3.58%) USD | NASDAQ | Apr 26, 16:00

0.7887 0.00 (0.00%) After-Hours: 16:06

Free Cash Flow (Quarterly) Chart

Historical Free Cash Flow (Quarterly) Data

View and export this data back to 2020. Upgrade now.

Date	Value
December 31, 2023	-22.66M
September 30, 2023	-20.35M
June 30, 2023	-13.61M
March 31, 2023	-22.39M
December 31, 2022	-16.87M
September 30, 2022	-17.14M
June 30, 2022	-25.37M
March 31, 2022	-20.95M

Date	Value
December 31, 2021	-37.82M
September 30, 2021	-25.46M
June 30, 2021	-23.17M
March 31, 2021	-30.10M
December 31, 2020	-19.74M
September 30, 2020	-16.91M
June 30, 2020	-18.26M
March 31, 2020	-21.41M

Free Cash Flow Definition

Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.

Read full definition.

Free Cash Flow (Quarterly) Range, Past 5 Years

-37.82M

Minimum

Dec 2021

-13.61M

Maximum

Jun 2023

-22.01M

Average

-21.18M

Median

Free Cash Flow (Quarterly) Benchmarks